00014 A PHASE II STUDY OF THE AGO OVARIAN CANCER STUDY GROUP (AGO-OVAR 2.6): ZD1839 IN COMBINATION WITH TAMOXIFEN IN REFRACTORY OVARIAN CANCER

Sehouli, J ; Wagner, U ; A du Bois ; Pfisterer, J ; Houber, J ; Loibl, S ; Lueck, H J ; Gropp, M ; Staehle, A ; Schmalfeldt, B ; Meier, W ; Jackisch, C

International journal of gynecological cancer, 2005-09, Vol.15 (Suppl 2), p.55-55 [Periódico revisado por pares]

Oxford: BMJ Publishing Group LTD

Texto completo disponível